Factors | Median survival (months) | P value | |
---|---|---|---|
Univariate analysis | Multivariate analysis | ||
Age (years) | Â | 0.821 | Â |
  ≤ 67 | 8.5 ± 5.5 |  |  |
  > 67 | 7.2 ± 4.7 |  |  |
Gender | Â | 0.225 | Â |
 Male | 8.5 ± 6.2 |  |  |
 Female | 6.3 ± 2.8 |  |  |
ECOG score | Â | <0.001 | 0.012 |
 0–1 | 9.5 ± 7.2 |  |  |
 2 | 3.8 ± 1.6 |  |  |
Etiology | Â | 0.153 | Â |
 Viral | 8.5 ± 5.5 |  |  |
 Non-viral | 6.6 ± 5.5 |  |  |
Child-Pugh class | Â | <0.001 | 0.026 |
 A | 8.5 ± 7.2 |  |  |
 B | 5.2 ± 1.6 |  |  |
AFP (ng/ml) | Â | 0.890 | Â |
  ≤ 400 | 8.5 ± 6.2 |  |  |
  > 400 | 7.2 ± 2.8 |  |  |
Albumin (g/dL) | Â | 0.003 | 0.076 |
  ≤ 3.6 | 6.6 ± 2.8 |  |  |
  > 3.6 | 15.2 ± 6.2 |  |  |
Hemoglobin (g/dL) | Â | 0.141 | Â |
  ≤ 11 | 6.6 ± 5.2 |  |  |
  > 11 | 9.5 ± 6.2 |  |  |
PVTT | Â | 0.541 | |
 Yes | 10.2 ± 5.5 |  |  |
 No | 6.6 ± 4.7 |  |  |
BED (Gy10) | Â | 0.836 | Â |
  ≤ 65.5 | 7.2 ± 5.5 |  |  |
  > 65.5 | 15.1 ± 1.6 |  |  |
RT duration (days) | Â | 0.443 | Â |
  ≤ 37 | 8.5 ± 5.5 |  |  |
  > 37 | 7.8 ± 2.8 |  |  |
Tumor response | Â | <0.001 | 0.016 |
 Yes | 27.8 ± 8.5 |  |  |
 No | 6.2 ± 2.8 |  |  |
Local control | Â | 0.007 | 0.011 |
 Yes | 13.2 ± 4.8 |  |  |
 No | 7.3 ± 2.6 |  |  |